AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 |Industry: Pharmaceuticals
|Expensive Performer
4217.60 -13.40 (-0.32%)
NSE Jan 15, 2021 15:31 PM
Volume: 45,139
 

4217.60
-0.32%
Why AstraZeneca-Oxford potential COVID vaccine works better in low dose
Why AstraZeneca-Oxford potential COVID vaccine works better in low dose
Moneycontrol
They have claimed that the drug is 70.4 percent effective, and it makes a strong case for AstraZeneca's India partner Serum Institute of India to seek licence for its potential vaccine, Covishield, in India.
default
Recommended
More from AstraZeneca Pharma India Ltd.